位置:首页 > 蛋白库 > HEMGN_MOUSE
HEMGN_MOUSE
ID   HEMGN_MOUSE             Reviewed;         503 AA.
AC   Q9ERZ0; B1AVH8; Q3TAE6; Q80YT2; Q8CF29;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   03-AUG-2022, entry version 119.
DE   RecName: Full=Hemogen;
DE   AltName: Full=Hemopoietic gene protein;
DE   AltName: Full=Negative differentiation regulator protein;
DE            Short=mNDR;
GN   Name=Hemgn; Synonyms=Ndr;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Fetal heart;
RX   PubMed=11404085; DOI=10.1016/s0925-4773(01)00376-8;
RA   Yang L.V., Nicholson R.H., Kaplan J., Galy A., Li L.;
RT   "Hemogen is a novel nuclear factor specifically expressed in mouse
RT   hematopoietic development and its human homologue EDAG maps to chromosome
RT   9q22, a region containing breakpoints of hematological neoplasms.";
RL   Mech. Dev. 104:105-111(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Liu C.-C., Ch'ang L.-Y.;
RT   "Effects of mNDR in spermatogenesis.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Embryo, Spleen, and Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=14648837; DOI=10.1002/dvdy.10399;
RA   Yang L.V., Heng H.H., Wan J., Southwood C.M., Gow A., Li L.;
RT   "Alternative promoters and polyadenylation regulate tissue-specific
RT   expression of Hemogen isoforms during hematopoiesis and spermatogenesis.";
RL   Dev. Dyn. 228:606-616(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103; SER-153; SER-158;
RP   SER-171; SER-213; SER-223; SER-241; SER-269; THR-286 AND SER-387, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Regulates the proliferation and differentiation of
CC       hematopoietic cells. Overexpression block the TPA-induced
CC       megakaryocytic differentiation in the K562 cell model. May also prevent
CC       cell apoptosis through the activation of the nuclear factor-kappa B
CC       (NF-kB) (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11404085}.
CC   -!- TISSUE SPECIFICITY: Expressed in hematopoietic precursor cells. Highly
CC       expressed in bone marrow, the red pulp of the spleen and round
CC       spermatids. Weakly expressed in peripheral blood cells.
CC       {ECO:0000269|PubMed:11404085, ECO:0000269|PubMed:14648837}.
CC   -!- DEVELOPMENTAL STAGE: Expressed at 8.5 dpc in the blood islands of the
CC       yolk sac and in the circulating primitive blood cells. Expressed in the
CC       circulating blood cells at 9.5 dpc and 10.5 dpc. Detected in the
CC       developing hepatic primordia at 10.5 dpc. From 11.5 dpc to 14.5 dpc,
CC       exclusively expressed in the fetal liver. {ECO:0000269|PubMed:11404085,
CC       ECO:0000269|PubMed:14648837}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF269248; AAG33367.1; -; mRNA.
DR   EMBL; AY699986; AAT94243.1; -; mRNA.
DR   EMBL; AK006588; BAC25148.2; -; mRNA.
DR   EMBL; AK077692; BAC36959.1; -; mRNA.
DR   EMBL; AK156536; BAE33747.1; -; mRNA.
DR   EMBL; AK171890; BAE42722.1; -; mRNA.
DR   EMBL; AL683884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050798; AAH50798.1; -; mRNA.
DR   CCDS; CCDS18150.1; -.
DR   RefSeq; NP_444379.1; NM_053149.2.
DR   AlphaFoldDB; Q9ERZ0; -.
DR   BioGRID; 220414; 3.
DR   STRING; 10090.ENSMUSP00000103393; -.
DR   iPTMnet; Q9ERZ0; -.
DR   PhosphoSitePlus; Q9ERZ0; -.
DR   EPD; Q9ERZ0; -.
DR   jPOST; Q9ERZ0; -.
DR   MaxQB; Q9ERZ0; -.
DR   PaxDb; Q9ERZ0; -.
DR   PeptideAtlas; Q9ERZ0; -.
DR   PRIDE; Q9ERZ0; -.
DR   ProteomicsDB; 269824; -.
DR   Antibodypedia; 14425; 206 antibodies from 24 providers.
DR   DNASU; 93966; -.
DR   Ensembl; ENSMUST00000071096; ENSMUSP00000066383; ENSMUSG00000028332.
DR   Ensembl; ENSMUST00000107764; ENSMUSP00000103393; ENSMUSG00000028332.
DR   GeneID; 93966; -.
DR   KEGG; mmu:93966; -.
DR   UCSC; uc008str.1; mouse.
DR   CTD; 55363; -.
DR   MGI; MGI:2136910; Hemgn.
DR   VEuPathDB; HostDB:ENSMUSG00000028332; -.
DR   eggNOG; ENOG502SBFR; Eukaryota.
DR   GeneTree; ENSGT00390000004522; -.
DR   HOGENOM; CLU_569802_0_0_1; -.
DR   InParanoid; Q9ERZ0; -.
DR   OMA; EIHQETP; -.
DR   OrthoDB; 801077at2759; -.
DR   PhylomeDB; Q9ERZ0; -.
DR   TreeFam; TF338654; -.
DR   BioGRID-ORCS; 93966; 2 hits in 73 CRISPR screens.
DR   PRO; PR:Q9ERZ0; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q9ERZ0; protein.
DR   Bgee; ENSMUSG00000028332; Expressed in fetal liver hematopoietic progenitor cell and 84 other tissues.
DR   Genevisible; Q9ERZ0; MM.
DR   GO; GO:0005654; C:nucleoplasm; IDA:MGI.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; ISO:MGI.
DR   InterPro; IPR033272; Hemogen.
DR   PANTHER; PTHR15993; PTHR15993; 3.
PE   1: Evidence at protein level;
KW   Developmental protein; Differentiation; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..503
FT                   /note="Hemogen"
FT                   /id="PRO_0000245362"
FT   REGION          1..129
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          7..87
FT                   /note="Necessary for nuclear localization"
FT                   /evidence="ECO:0000250"
FT   REGION          381..503
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        76..112
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        423..437
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        482..503
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         90
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AZ54"
FT   MOD_RES         103
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         124
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXL5"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         158
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         171
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         223
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         228
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXL5"
FT   MOD_RES         241
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         269
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         286
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         387
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AZ54"
FT   CONFLICT        472
FT                   /note="E -> G (in Ref. 5; AAH50798)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   503 AA;  55043 MW;  B1027B81B55BB08D CRC64;
     MDMGKGRPRL KLPQMPEAHP QKSCAPDIIG SWSLRNREQL RKRKAEAQGR QTSQWLLGEQ
     KKRKYQRTGK GNKRGRKRQG NVEQKAEPWS QTERERVQEV LVSAEEETEH PGNSATEALP
     LVPSPTKAVP ADQCSEAHQE SIQCQERAIQ NHSQTHLSPT TCQGIAVLQH SPKMCQDMAE
     PEVFSPNMCQ ETAVPQTYPP KALEEMAAAE PLSPKMCQET TVSPNHSSKV PQDMAGPEAL
     SPNMCQEPTV PQEHTLKMCH DVARPEVLSP KTHQEMAVPK AFPCVTPGDA AGLEGCAPKA
     LPQSDVAEGC PLDTTPTSVT PEQTTSDPDL GMAVTEGFFS EARECTVSEG VSTKTHQEAV
     EPEFISHETY KEFTVPIVSS QKTIQESPEP EQYSPETCQP IPGPENYSLE TCHEMSGPED
     LSIKTCQDRE EPKHSLPEGA QKVGGAQGQD ADAQDSENAG AFSQDFTEME EENKADQDPE
     APASPQGSQE TCPENGIYSS ALF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024